tiprankstipranks
Advertisement
Advertisement

OGEN Stock Latest News

Oragenics Faces NYSE Compliance Challenges Amid Trial Progress
Company AnnouncementsOragenics Faces NYSE Compliance Challenges Amid Trial Progress
8d ago
8K
OGEN
Oragenics Appoints New Chief Financial Officer and Leader
PremiumCompany Announcements
Oragenics Appoints New Chief Financial Officer and Leader
2M ago
8K
OGEN
Oragenics Highlights Investor Outreach at Micro-Cap Conference
PremiumCompany Announcements
Oragenics Highlights Investor Outreach at Micro-Cap Conference
4M ago
8K
OGEN
Oragenics announces 8 drug doses administered in Phase IIa trial of ONP-002
PremiumThe Fly
Oragenics announces 8 drug doses administered in Phase IIa trial of ONP-002
5M ago
OGEN
Oragenics begins Phase IIa dosing of concussion drug ONP-002 in Australia
PremiumCompany Announcements
Oragenics begins Phase IIa dosing of concussion drug ONP-002 in Australia
5M ago
OGEN
Oragenics Sets New 2025 Annual Shareholder Meeting Date
PremiumCompany AnnouncementsOragenics Sets New 2025 Annual Shareholder Meeting Date
5M ago
8K
OGEN
Oragenics receives audit opinion with going concern explanation
Premium
The Fly
Oragenics receives audit opinion with going concern explanation
5M ago
OGEN
Oragenics files annual report on Form 10-K
Premium
The Fly
Oragenics files annual report on Form 10-K
6M ago
OGEN
Oragenics initiates Phase IIa clinical trial site activation
PremiumThe Fly
Oragenics initiates Phase IIa clinical trial site activation
6M ago
OGEN
Oragenics Advances Concussion Drug Trial and Explores CNS Asset Acquisitions
PremiumCompany Announcements
Oragenics Advances Concussion Drug Trial and Explores CNS Asset Acquisitions
6M ago
OGEN
Oragenics explores potential acquisition of additional assets in CNS space
PremiumThe Fly
Oragenics explores potential acquisition of additional assets in CNS space
6M ago
OGEN
Oragenics receives HREC approval for Phase IIa trial of ONP-002 in Australia
PremiumThe Fly
Oragenics receives HREC approval for Phase IIa trial of ONP-002 in Australia
6M ago
OGEN
Oragenics previews targeted milestones for 2026
PremiumThe FlyOragenics previews targeted milestones for 2026
7M ago
OGEN
Oragenics partners with Duck Flats Pharma to support FDA IND trial design
Premium
The Fly
Oragenics partners with Duck Flats Pharma to support FDA IND trial design
7M ago
OGEN
Oragenics Extends At-the-Market Equity Sales Agreement
Premium
Company Announcements
Oragenics Extends At-the-Market Equity Sales Agreement
8M ago
8K
OGEN
Oragenics files $100M mixed securities shelf
PremiumThe Fly
Oragenics files $100M mixed securities shelf
8M ago
OGEN
Oragenics Adjusts Executive Compensation Plan
PremiumCompany Announcements
Oragenics Adjusts Executive Compensation Plan
9M ago
8K
OGEN
Oragenics Regains NYSE Compliance After Public Offering
PremiumCompany Announcements
Oragenics Regains NYSE Compliance After Public Offering
11M ago
8K
OGEN
Oragenics regains compliance with NYSE
PremiumThe Fly
Oragenics regains compliance with NYSE
11M ago
OGEN
Oragenics, Receptor.AI partner to accelerate pipeline development
PremiumThe FlyOragenics, Receptor.AI partner to accelerate pipeline development
11M ago
OGEN
Oragenics Appoints Natasha Giordano to Board of Directors
Premium
Company Announcements
Oragenics Appoints Natasha Giordano to Board of Directors
1y ago
8K
OGEN
Oragenics reports Q2 EPS ($3.10) vs. ($15.27) last year.
Premium
The Fly
Oragenics reports Q2 EPS ($3.10) vs. ($15.27) last year.
1y ago
OGEN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >